Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Beneficial effects of UV radiation other than via vitamin D production.
Phase 3 Efficacy and Tolerability Study of OnabotulinumtoxinA for Urinary Incontinence From Neurogenic Detrusor Overactivity.
Effect of short-term interferon-β treatment on cytokines in multiple sclerosis: Significant modulation of IL-17 and IL-23.
IL-17: A new actor in IFN-driven systemic autoimmune diseases.
Severe relapses under fingolimod treatment prescribed after natalizumab.
A personalized, intense physical rehabilitation program improves walking in people with multiple sclerosis presenting with different levels of disability: a retrospective cohort.
Murine experimental autoimmune encephalomyelitis is diminished by treatment with the angiogenesis inhibitors b20-4.1.1 and angiostatin (k1-3).
Simvastatin reduces the expression of adhesion molecules in circulating monocytes from hypercholesterolemic patients.
Alemtuzumab and multiple sclerosis: Is it safe?
Structural features of the Nogo receptor signaling complexes at the neuron/myelin interface.
Correlation of midkine serum level with pro- and anti-inflamatory cytokines in multiple sclerosis.
Features of neuromyelitis optica spectrum disorders and aquaporin-4 with myelin-oligodendrocyte glycoprotein antibodies-reply.
Mesenchymal Stem Cell-Based Therapy in a Mouse Model of Experimental Autoimmune Encephalomyelitis (EAE).
Latin American algorithm for treatment of relapsing-remitting multiple sclerosis using disease-modifying agents.
Mitochondrial Complex Enzyme Activities and Cytochrome c Expression Changes in Multiple Sclerosis.
Incidence and Prevalence of Multiple Sclerosis in the Americas: A Systematic Review.
Sativex(®) and clinical-neurophysiological measures of spasticity in progressive multiple sclerosis.
Correction to: Multiple sclerosis in the Levant: a regional consensus statement.
Meta-analysis of prevalence.
Molecular grafting onto a stable framework yields novel cyclic peptides for the treatment of multiple sclerosis.
Hypoperfusion and T1-hypointense lesions in white matter in multiple sclerosis.
Mild phenotype of Charcot-Marie-Tooth disease type 4B1.
Risk of fractures in patients with multiple sclerosis: A population-based cohort study.
Multiple sclerosis: TNF receptor 1 gene variant could explain failure of TNF-blocking drugs in multiple sclerosis.
What is needed to keep persons with multiple sclerosis vitamin D-sufficient throughout the year?
Pages
« first
‹ previous
…
282
283
284
285
286
287
288
289
290
…
next ›
last »